Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 995 | 1070 | 1029 | 1173 | 1301 | 1899 |
Fund Return | -0.47% | 6.97% | 2.89% | 5.47% | 5.4% | 6.62% |
Place in category | 174 | 57 | 102 | 115 | 70 | 9 |
% in Category | 41 | 14 | 24 | 27 | 22 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FC Responsible Global Equity 1 Acc | 1.32B | 5.68 | 5.70 | 11.23 | ||
FC Responsible Global Equity 1 Inc | 1.32B | 5.64 | 5.43 | 11.09 | ||
FC Responsible Global Equity 2 Acc | 1.32B | 5.81 | 6.53 | 12.17 | ||
FC Responsible Global Equity 4 Inc | 1.32B | 5.95 | 7.30 | 12.94 | ||
FC Responsible Global Equity Fund 2 | 1.32B | 7.35 | 4.18 | 12.44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Liontrust Special Situations Fund R | 41.61M | -1.48 | 2.55 | 6.09 | ||
Liontrust Special Situations Fund A | 6.14M | 0.92 | 2.88 | 7.38 | ||
Liontrust Special Situations Fund I | 2.9B | 1.61 | 1.63 | 7.61 | ||
Fidelity Special Situations Fund W | 2.35B | 7.57 | 7.23 | 6.79 | ||
Fidelity Special Situations | 438.58M | -1.00 | 7.74 | 4.82 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.54 | 12,296.0 | -0.87% | |
Unilever | GB00B10RZP78 | 4.20 | 50.52 | +0.16% | |
Experian | GB00B19NLV48 | 3.16 | 3,711.0 | -0.32% | |
Ashtead Group | GB0000536739 | 3.01 | 5,714.0 | -0.04% | |
GSK plc | GB00BN7SWP63 | 2.96 | 1,774.50 | -0.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review